SynthesisFrontiers in immunology2025

Efficacy and safety of pembrolizumab for the treatment of advanced or recurrent ovarian cancer: a meta-analysis based on single-arm studies.

Xiaodong Mi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.